Glenmark launches dry powder inhaler Tavulus in Spain

Glenmark launches dry powder inhaler Tavulus in Spain

by admin- Monday, October 11th, 2021 04:57:22 PM

Glenmark Pharmaceuticals announced the release of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) below the brand name Tavulus® in Spain, for the treatment of chronic obstructive pulmonary disease (COPD).

News Updates